论著

单侧甲状腺乳头状癌Delphian淋巴结转移的发生率及其临床意义

展开
  • 复旦大学附属中山医院普外科,上海 200032

收稿日期: 2020-08-10

  网络出版日期: 2022-07-22

基金资助

上海市“科技创新行动计划”自然科学基金(21ZR1412000)

Incidence of Delphian lymph node metastasis in unilateral papillary thyroid carcinoma and clinical significance

Expand
  • Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China

Received date: 2020-08-10

  Online published: 2022-07-22

摘要

目的:探究喉前淋巴结(Delphian lymph node, DLN)转移在单侧甲状腺乳头状癌(papillary thyroid carcinoma, PTC)病人中的发生率及其临床意义。方法:回顾性分析我科2016年1月至2019年12月收治522例单侧PTC病人的临床病理资料。分析DLN转移与病人年龄、性别、肿瘤大小、肿瘤多灶性、包膜侵犯、腺体外侵犯、肿瘤位置、中央区淋巴结转移(除外DLN)和侧颈区淋巴结转移的关系。结果:522例中,133例(25.5%)DLN转移。年龄(P=0.047)、性别(P<0.001)、肿瘤最大径(P<0.001)、包膜侵犯(P<0.001)、腺体外侵犯(P=0.004)、肿瘤位置(P=0.003)、中央区淋巴结转移(P<0.001) 及其数目(除外DLN)(P<0.001)、侧颈区淋巴结转移(P=0.036)及其数目(P=0.004)、DLN切除数目(P=0.043)与DLN转移相关。结论:DLN转移与PTC的一些不良预后因素显著相关。如术中冷冻病理检查结果提示DLN转移阳性,需仔细清扫并评估中央区淋巴结以及侧颈区淋巴结,密切随访。

本文引用格式

刘威, 王聪, 王正林, 艾志龙 . 单侧甲状腺乳头状癌Delphian淋巴结转移的发生率及其临床意义[J]. 外科理论与实践, 2021 , 26(05) : 445 -448 . DOI: 10.16139/j.1007-9610.2021.05.017

Abstract

Objects To study the incidence of Delphian lymph node (DLN) metastasis in patients with unilateral pa-pillary thyroid carcinoma (PTC) and the clinical significance. Methods The clinicopathological data of 522 patients with unilateral PTC in our hospital between January 2016 and December 2019 were analyzed retrospectively. The association between DLN metastasis and the clinicopathological characteristics including age, sex, tumor size, multifocality, capsular invasion, extrathyroidal extension, tumor location, central lymph node (CLN) metastasis (excluding DLN), and lateral lymph node metastasis was analyzed. Results One hundred thirty-three(25.5%) of 522 patients had DLN metastasis. It was significant that DLN metastasis was associated with age (P=0.047), male (P<0.001), larger tumor size (P<0.001), capsular invasion (P<0.001), extrathyroidal extension (P=0.004), tumor location (P=0.003), CLN metastasis (P<0.001), number of positive CLN (excluding DLN) (P<0.001), lateral compartment lymph node (LLN) metastasis (P=0.036), number of positive LLN (P=0.004) and number of DLN removed (P=0.043). Conclusions The DLN metastasis was shown to be associated significantly with several factors of poor PTC prognosis. When the DLN of intraoperative frozen section is positive, careful dissection and evaluation of CLN and LLN are essential with necessary follow-up.

参考文献

[1] Shaha AR, Shah JP, Loree TR. Patterns of nodal and distant metastasis based on histologic varieties in diffe-rentiated carcinoma of the thyroid[J]. Am J Surg, 1996, 172(6):692-694.
[2] Schoppy DW, Holsinger FC. Management of the neck in thyroid cancer[J]. Otolaryngol Clin North Am, 2014, 47(4):545-556.
[3] Haugen BR, Alexander EK, Bible KC, et al. 2015 Ame-rican Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer[J]. Thyroid, 2016, 26(1):1-133.
[4] Means J. The thyroid and its diseases[M]. 2nd ed. Philadelphia: JB Lippincott Co., 1948.
[5] Gawlak-Prycka A. Prelaryngeal lymph node (Delphian) in patients with laryngeal cancer[J]. Otolaryngol Pol, 2001, 55(1):35-41.
[6] Ferlito A, Shaha AR, Rinaldo A. Prognostic value of Delphian lymph node metastasis from laryngeal and hypopharyngeal cancer[J]. Acta Otolaryngol, 2002, 122(4):456-457.
[7] Isaacs JD, Lundgren CI, Sidhu SB, et al. The Delphian lymph node in thyroid cancer[J]. Ann Surg, 2008, 247(3):477-482.
[8] Iyer NG, Kumar A, Nixon IJ, et al. Incidence and significance of Delphian node metastasis in papillary thyroid cancer[J]. Ann Surg, 2011, 253(5):988-991.
[9] Kim WW, Yang SI, Kim JH, et al. Experience and ana-lysis of Delphian lymph node metastasis in patients with papillary thyroid carcinoma[J]. World J Surg Oncol, 2012, 10:226.
[10] Lee YC, Shin SY, Kwon KH, et al. Incidence and clinical characteristics of prelaryngeal lymph node metastasis in papillary thyroid cancer[J]. Eur Arch Otorhinolaryngol, 2013, 270(9):2547-2550.
[11] Oh EM, Chung YS, Lee YD. Clinical significance of Delphian lymph node metastasis in papillary thyroid carci-noma[J]. World J Surg, 2013, 37(11):2594-2599.
[12] Tan Z, Ge MH, Zheng CM, et al. The significance of Delphian lymph node in papillary thyroid cancer[J]. Asia Pac J Clin Oncol, 2017, 13(5):e389-e393.
[13] Zheng G, Zhang H, Hao S, et al. Patterns and clinical significance of cervical lymph node metastasis in papillary thyroid cancer patients with Delphian lymph node metastasis[J]. Oncotarget, 2017, 8(34):57089-57098.
[14] Gimm O, Rath FW, Dralle H. Pattern of lymph node metastases in papillary thyroid carcinoma[J]. Br J Surg, 1998, 85(2):252-254.
[15] Qubain SW, Nakano S, Baba M, et al. Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma[J]. Surgery, 2002, 131(3):249-256.
[16] Roh JL, Kim JM, Park CI. Central lymph node metastasis of unilateral papillary thyroid carcinoma: patterns and factors predictive of nodal metastasis, morbidity, and recurrence[J]. Ann Surg Oncol, 2011, 18(8):2245-2250.
[17] Podnos YD, Smith D, Wagman LD, et al. The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer[J]. Am Surg, 2005, 71(9):731-734.
文章导航

/